With Lash Group, the Promise of High-Tech and High-Touch is Possible
eServices Powered by Lash Group
Where innovation and heart drive patient access
Award-Winning Technology and Analytics Ecosystem
Empowered patient support
Delivering solutions with empathy and expertise
Committed to excellence
- Launch Center of Excellence
- Quality Compliance and Regulatory Excellence
- Reporting & Analytical Insights
- Recruiting and Training
We pioneered this industry
- 30+ years of experience in the patient support industry
- Served over 12 million patients
- Currently operating over 100 million patient programs
- Nearly 400,000 claims processed annually
Accelerating speed to therapy
Next-gen benefit verification begins now
Case Study: Improving Speed to Therapy With Provider Portals
Innovative therapies make innovative patient services essential. Learn how Lash Group helped one manufacturer improve speed and access to therapy with an electronic provider portal for benefit verification and prior authorization.
The Promise and the Reality of Artificial Intelligence in Electronic Benefit Verification
Making medications more affordable
Copay Accumulators: Are Your Patients Really at Risk?
Corey Ford, MHA
Two experts in health economics and patient support team up to offer insight on how manufacturers can prepare for the impact of copay accumulators.
Electronic PAP: New Technology Solutions to Streamline the Eligibility and Enrollment Process
Breaking down adherence barriers
Lash Group to Amplify Patient Engagement Capabilities with AllazoHealth Artificial Intelligence and Predictive Analytics Tool
Lash Group and Medisafe form Strategic Collaboration to Advance Patient Adherence by Deploying Mobile Engagement Before the First Fill
How Tech-Enabled Solutions Impact Adherence
Tommy Bramley, PhD
Executive Q&A: The market trends and technology solutions impacting medication adherence today.
High-Tech Trends: How Patient Adherence and Engagement Solutions Are Evolving
How adherence solutions are evolving -- with some high-tech help. Originally published on FiercePharma.com.